The Olmsted NAFLD Epidemiology Study (TONES)
This study, called TONES, is looking at how common Non-Alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) are in the community. Researchers want to understand these liver conditions better and create ways to diagnose them earlier. You might be eligible if you live in Olmsted County, are 18 or older, and haven't been diagnosed with NAFLD before. The study involves diagnostic tests like Magnetic Resonance Elastography (MRE), blood draws, and potentially a liver biopsy or Fibro Scan. The main goal is to find out the prevalence of NAFLD and NASH in the population over five years. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 800 participants. It aims to understand the prevalence of NAFLD and NASH in the population.
- What's involved
- You would undergo diagnostic tests such as Magnetic Resonance Elastography (MRE) and blood draws. A liver biopsy or Fibro Scan may also be performed if indicated by MRE results.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, prevalence of NAFLD and NASH, will be measured at 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Olmsted NAFLD Epidemiology Study (TONES)
At a glance
Conditions
NCT04365855
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Mayo Clinic in Rochester
Rochester, Minnesotano site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- ALINA M ALLEN, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Prevalence of NAFLD and NASH in the population5 years
Number of subjects with NAFLD and NASH determined by the MRE